AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
FDA Warns Antidepressants Could Trigger Suicidal Behavior.
Mar. 23--Children and adults who take antidepressants should be monitored for suicidal behavior, and pharmaceutical companies should provide patients with warnings about the drugs, the federal Food and Drug Administration said Monday.
The move is the most direct indication yet that anti-depressants, while helping millions of people, could also have potentially dangerous side effects. The drugs are one of the most commonly prescribed medications in the United States.
The FDA made its recommendations while studies are being conducted to determine what role, if any, antidepressants may play in provoking suicidal behavior.
While worried patients began calling doctors Monday, mental health experts warned that severely depressed patients should not stop taking medications precipitously. Untreated depression can be devastating and more risky than taking the drugs, they said.
"It is wonderful that people are looking at these medications under a magnifying glass," said Louis Kraus, head of child psychiatry at Rush University Medical Center. "But people should not be too quick to jump to conclusions simply because they're looking at it. It truly would be a tragedy if kids with severe depression, or adults for that…
- Antidepressants raise risk of suicidal behavior for young adults, FDA says.
- News wire article from: The America's Intelligence Wire December 5, 2006 700+ words
...much so that the FDA would only conclude...neutral effect on suicidal behavior for them but possibly...suicidality and suicidal behavior among adults younger...population," the FDA said in documents...GlaxoSmithKline and the FDA warned Paxil may raise the risk of ...
- FDA okays new indication for Clozaril. (RX Marketplace).(Novartis...
- Magazine article from: Chain Drug Review January 20, 2003 700+ words
...approval of Clozaril as a treatment of recurrent suicidal behavior in patients with schizophrenia or schizoaffective...medication has been approved for use in treating suicidal behavior. According to the FDA, the annual number of suicides associated...
- FDA Committee Recommends Approval for Clozaril(R) to Treat Suicidal Behavior.
- Press release article from: PR Newswire November 4, 2002 700+ words
...to recommend that the FDA approve the use of Clozaril...treatment of emergent suicidal behavior in patients with schizophrenia...schizoaffective disorder. FDA reviewers will consider...R). "Today's FDA Advisory Committee recommendation...risk of suicide and suicidal behavior ...
- FDA Approves Clozaril(R) to Reduce the Risk of Suicidal Behavior; - Drug is...
- Press release article from: PR Newswire December 19, 2002 700+ words
...Drug Administration (FDA) to market Clozaril...treatment of recurrent suicidal behavior in patients with schizophrenia...This action by the FDA marks the first time...use in treatment of suicidal behavior. Although generic versions...Clozaril are available, FDA regulations ...
- FDA Warns Antidepressants Could Trigger Suicidal Behavior.
- Newspaper article from: Knight Ridder/Tribune Business News March 23, 2004 700+ words
...United States. The FDA made its recommendations...may play in provoking suicidal behavior. While worried patients...thinking and actions, the FDA said. There have been conflicting reports of suicidal behavior in some studies of children...matter is settled, the FDA said, it is ...
- New Report Concludes SSRI Antidepressants Do Not Increase Suicidal Behavior in...
- Press release article from: PR Newswire January 21, 2004 700+ words
...may increase the risk for suicide. The FDA is convening an advisory committee hearing...recommendations. ACNP urged that all data held by FDA or pharmaceutical companies should be made...substantial amount of data available to the FDA or to pharmaceutical companies." The full...
- The FDA is examining data on GlaxoSmithKline's antidepressant paroxetine...
- Magazine article from: Medical Marketing & Media August 1, 2003 700+ words
The FDA is examining data on GlaxoSmithKline's antidepressant paroxetine (Paxil) concerning an increased incidence of suicidal behavior in patients under 18 years of age. The agency and company have been negotiating whether any pediatric-use warning is necessary.
- Study: Clozaril reduces risk of suicidal behavior 26%.
- Newspaper article from: Drug Week February 14, 2003 700+ words
...medication to affect suicidal behavior in any patient group...Drug Administration (FDA) approved Clozaril for treatment of recurrent suicidal behavior in patients with schizophrenia...Clozaril are available, FDA regulations provide...
- Study Shows Clozaril Reduces Risk of Suicidal Behavior Among Patients with...
- Press release article from: PR Newswire January 13, 2003 700+ words
...medication to affect suicidal behavior in any patient group...Drug Administration (FDA) approved Clozaril...treatment of recurrent suicidal behavior in patients with schizophrenia...R) are available, FDA regulations provide...
- ACNP Issues Final Report on SSRIs and Suicidal Behavior in Youth.
- Press release article from: PR Newswire November 23, 2005 700+ words
...thoughts and nonfatal suicidal behavior found in an analysis...Drug Administration (FDA) database of adverse...Report on SSRIs and Suicidal Behavior in Youth. The report...September 2004, the FDA decided to require a...
Source: HighBeam Research, FDA Warns Antidepressants Could Trigger Suicidal Behavior.
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
